Back to Search
Start Over
Comparison of Doxycycline and Benzathine Penicillin G for the Treatment of Early Syphilis.
- Source :
-
Acta dermatovenerologica Croatica : ADC [Acta Dermatovenerol Croat] 2017 Jul; Vol. 25 (2), pp. 107-111. - Publication Year :
- 2017
-
Abstract
- Doxycycline is the preferred recommended second-line treatment for the treatment of early syphilis. Recent reports showed a declining efficacy trend of doxycycline in treatment of early syphilis. The aim of our study was to assess the serological response to the treatment for early syphilis with doxycycline compared with benzathine penicillin G and evaluate whether doxycycline is still an effective agent for the treatment of early syphilis. A record-based retrospective study was conducted. Patients were diagnosed with early syphilis in an sexually transmitted disease (STD) clinic from January 1, 2008 to December 31, 2014. They were treated with a single dose of benzathine penicillin G 2.4MU or oral doxycycline 100 mg twice daily for 14 days. Pearson's chi-squared test was used for data analysis. 601 cases were included in the final study sample: 105 (17.5%) patients received a 14-day course of doxycycline (doxycycline group), and 496 (82.5%) patients received single-dose benzathine penicillin G (BPG group). The serological responses at 6 months and 12 months after treatment were compared. No statistically significant differences were found between the two groups at 6 months (69.52% vs. 75.00%, P=0.245), and at 12 months (92.38% vs. 96.17%, P=0.115). Doxycycline is still an effective agent for the treatment of early syphilis.
Details
- Language :
- English
- ISSN :
- 1847-6538
- Volume :
- 25
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Acta dermatovenerologica Croatica : ADC
- Publication Type :
- Academic Journal
- Accession number :
- 28871924